5 Results for "

Mesoporous silica nanoparticles

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Mesoporous silica nanoparticles" in MCE Product Catalog:

Poly(acrylic acid) (MW 250000)
Poly(acrylic acid) (MW 250000)
0 Images
Cat. No.: HY-W243303J
CAS No.: 9003-01-4
Poly(acrylic acid) (MW 250000) is a synthetic cationic electrolyte containing abundant carboxyl groups (-COOH), which exhibits excellent water absorption and retention properties and is often cross-linked to form hydrogels. Poly(acrylic acid) (with a molecular weight of 250,000). Poly(acrylic acid) (MW 250000) can be used as a non-collagenous analog in the biomimetic mineralization research of type I collagen. Poly(acrylic acid) (MW 250000) has pH responsiveness and biocompatibility and is often used as a drug carrier, surface modifier and functional material .
loading...
    loading...
View All Sizes
BMP2-derived peptide
BMP2-derived peptide
0 Images
Cat. No.: HY-P5832
CAS No.: 836606-84-9
Target:  

TGF-beta/Smad RUNX

Research Areas:  

Metabolic Disease

BMP2-derived peptide is an osteogenic inducer and BMP receptor ligand. BMP2-derived peptide binds to BMP receptors on the cell surface to form a complex, activates the downstream Smad signaling pathway, and regulates the expression of osteogenic transcription factors. BMP2-derived peptide effectively promotes the adhesion, proliferation, osteogenic differentiation and mineralization of bone marrow mesenchymal stem cells, significantly up-regulates the mRNA levels of OCN, Runx2 and type I collagen, and increases alkaline phosphatase activity and calcium deposition. BMP2-derived peptide induces osteoblast differentiation and ectopic bone regeneration, and improves cranial bone defect repair. Meanwhile, BMP2-derived peptide enhances the cytocompatibility of mesoporous silica nanoparticles, synergistically increases osteogenic activity with Dexamethasone (HY-14648), serving as an important tool for bone defect repair research .
loading...
    loading...
View All Sizes
BHQ-2 NHS
BHQ-2 NHS
0 Images
Cat. No.: HY-42984
CAS No.: 916753-62-3
BHQ-2 NHS is a fluorescence dark quencher with an absorption spectrum spanning 550-650 nm that overlaps with tetramethylrhodamine (TMR) emission. BHQ-2 NHS quenches TMR fluorescence when conjugated to mesoporous silica nanoparticles. BHQ-2 NHS can be used for the research of cancer .
loading...
    loading...
View All Sizes
DBCO-PEG5000-Amine
DBCO-PEG5000-Amine
0 Images
Cat. No.: HY-174929A
Synonyms: DBCO-PEG5000-NH2
DBCO-PEG5000-Amine (DBCO-PEG5000-NH2) is a polyethylene glycol derivative containing dibenzocyclooctyne. DBCO-PEG-Amine is a universal, modular "bridge molecule": it forms stable covalent linkage with target materials (e.g., MSN or polymers) via the amino group at one end, while the DBCO group at the other end enables efficient, specific, and biocompatible click chemical conjugation with any azide-bearing biological entities (e.g., bacteria, cells) in subsequent steps .
loading...
    loading...
View All Sizes
VHPKQHR
VHPKQHR
0 Images
Cat. No.: HY-P11887
CAS No.: 1174559-81-9
Target:  

Transmembrane Glycoprotein Radionuclide-Drug Conjugates (RDCs)

Research Areas:  

Inflammation/Immunology

VHPKQHR is a peptide-based delivery enhancer that binds to VCAM-1. VHPKQHR enables intracellular internalization of relevant nanomaterials and facilitates the targeted delivery of miRNA inhibitors to inflamed endothelial cells and endothelial cells activated by disturbed flow. When conjugated with magnetic mesoporous silica nanoparticles, VHPKQHR achieves targeted accumulation at atherosclerotic plaque sites. When displayed on the surface of polyelectrolyte complex micelles, VHPKQHR enhances the relevant effects of anti-miR-92a in Apoe -/- mice. When conjugated with ultrasmall superparamagnetic iron oxide nanoparticles, VHPKQHR forms a contrast agent for T1-weighted magnetic resonance imaging. VHPKQHR can be used in research related to atherosclerosis, stenosis and rheumatoid arthritis .
loading...
    loading...
View All Sizes
Assay Types